Nuwellis (NUWE) EBT Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | -3,073.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,073.00 |
| Dec 31, 2025 | 20,495.00 |
| Sep 30, 2025 | -7,851.00 |
| Jun 30, 2025 | -37,547.00 |
| Mar 31, 2025 | 7,482.00 |
| Dec 31, 2024 | 63,461.00 |
| Sep 30, 2024 | 23,925.00 |
| Jun 30, 2024 | -11,861.00 |
| Mar 31, 2024 | 12,197.00 |
| Dec 31, 2023 | -75,705.00 |
| Sep 30, 2023 | 4,768.00 |
| Jun 30, 2023 | -3,981.00 |
| Mar 31, 2023 | -12,290.00 |
| Dec 31, 2022 | 80,701.00 |
| Sep 30, 2022 | 9,709.00 |
| Jun 30, 2022 | -507.00 |
| Mar 31, 2022 | 3,997.00 |
| Dec 31, 2021 | -11,309.00 |
| Sep 30, 2021 | -6,082.00 |
| Jun 30, 2021 | 2,190.00 |
| Mar 31, 2021 | 802.00 |
| Dec 31, 2020 | 17,301.00 |
| Sep 30, 2020 | 13,648.00 |
| Jun 30, 2020 | 5,363.00 |
| Mar 31, 2020 | 10,877.00 |
| Dec 31, 2019 | -4,203.00 |
| Sep 30, 2019 | -4,899.00 |
| Jun 30, 2019 | 11,621.00 |
| Mar 31, 2019 | 3,098.00 |
| Dec 31, 2018 | 57,404.00 |
| Sep 30, 2018 | -1,411.00 |
| Jun 30, 2018 | -9,588.00 |
| Mar 31, 2018 | -31,554.00 |
| Dec 31, 2017 | -46,607.00 |
| Sep 30, 2017 | 43,636.00 |
| Mar 31, 2015 | -123,051.00 |
| Sep 30, 2014 | 6,610.00 |